PharmaCyte Biotech Inc (PMCB)

[1234jklm]

They were waiting on the ability to create cells to cGMP standard which was the missing link when the ciab system was stalled twenty years ago.

Claims on this board that no one wanted the treatment for 20 years are true.

But Mr Waggoner had the insight and vision to see that austrianova could create cell banks to cGMP standards to make this delivery system incredibly valuable.

And by the 3rd quarter of this year those cell banks will be ready for testing with ciab.

Hence the delays to FDA IND submission.

His vision is now proving to be quite brilliant for both investors and cancer patients.

He deserves all the salary and shares and holidays in the world for his belief and vision imho.